Literature DB >> 12882465

Mortality during hospitalisation for pneumonia in Alberta, Canada, is associated with physician volume.

T J Marrie1, K C Carriere, Y Jin, D H Johnson.   

Abstract

The association of mortality with patient factors (severity of illness, comorbidity), physician factors (specialty training, prehospitalisation visit, in-hospital consultation, volume of patients seen per physician) and healthcare organisation factors (patient-travel distances, regional beds per capita, admitting hospital-bed occupancy, admitting hospital-bed turnover, hospital location, volume of pneumonia cases per hospital) after hospital admission with community-acquired pneumonia was investigated using administrative data from Alberta, Canada from April 1, 1994-March 31, 1999. During the 5-yr study period there were 43,642 pneumonia hospitalisations, with an 11% in-hospital and 26% 1-yr mortality. Patient severity of illness and comorbidity were the strongest predictors of increased mortality. Physicians with the highest in-hospital pneumonia patient volume (>27 patients x yr(-1)) cared for patients with greater severity/comorbidity, but with decreased odds of in-hospital mortality, compared with the lowest volume physicians (less than seven patients per year). The effects of internal medicine specialist or subspecialist care were mixed, with a reduction in deaths for the first 72 h and an increase in in-hospital deaths. Prehospitalisation visit by a physician was associated with decreased mortality. Healthcare organisation factors were the least strong predictor of mortality, demonstrating an effect only for 1-yr mortality in those discharged alive from hospital. Admissions to larger volume or metropolitan hospitals were associated with a decrease in mortality. Severity of illness and comorbidity had the strongest association with mortality. The first association of high-volume physician and pre-hospital care with decreased in-hospital mortality for community-acquired pneumonia is reported.

Entities:  

Mesh:

Year:  2003        PMID: 12882465     DOI: 10.1183/09031936.03.00115703

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  8 in total

1.  Factors associated with pneumonia outcomes: a nationwide population-based study over the 1997-2008 period.

Authors:  Guann-Ming Chang; Yu-Chi Tung
Journal:  J Gen Intern Med       Date:  2011-11-18       Impact factor: 5.128

Review 2.  [Assessment, triage, and follow-up of a patient with: acute CAP COPD].

Authors:  K Faure
Journal:  Med Mal Infect       Date:  2006-11-07       Impact factor: 2.152

3.  Does physicians' case volume impact inpatient care costs for pneumonia cases?

Authors:  Hsiu-Chen Lin; Sudha Xirasagar; Herng-Ching Lin; Yi-Ting Hwang
Journal:  J Gen Intern Med       Date:  2007-11-28       Impact factor: 5.128

4.  Factors influencing in-hospital mortality in community-acquired pneumonia: a prospective study of patients not initially admitted to the ICU.

Authors:  Thomas J Marrie; Lieling Wu
Journal:  Chest       Date:  2005-04       Impact factor: 9.410

5.  Capturing the trends in hospital standardized mortality ratios for pneumonia: a retrospective observational study in Japan (2010 to 2018).

Authors:  Rebeka Amin; Yosuke Hatakeyama; Takefumi Kitazawa; Kunichika Matsumoto; Shigeru Fujita; Kanako Seto; Tomonori Hasegawa
Journal:  Environ Health Prev Med       Date:  2020-01-07       Impact factor: 3.674

Review 6.  Advances in community-acquired pneumonia.

Authors:  Barbara Jones; Grant Waterer
Journal:  Ther Adv Infect Dis       Date:  2020-11-06

7.  Long-term mortality of hospitalized pneumonia in the EPIC-Norfolk cohort.

Authors:  P K Myint; K R Hawkins; A B Clark; R N Luben; N J Wareham; K-T Khaw; A M Wilson
Journal:  Epidemiol Infect       Date:  2015-08-24       Impact factor: 2.451

8.  Association between hospital case volume and mortality in non-elderly pneumonia patients stratified by severity: a retrospective cohort study.

Authors:  Hiraku Kumamaru; Yusuke Tsugawa; Hiromasa Horiguchi; Kanako Kunishima Kumamaru; Hideki Hashimoto; Hideo Yasunaga
Journal:  BMC Health Serv Res       Date:  2014-07-12       Impact factor: 2.655

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.